Related references
Note: Only part of the references are listed.Dickkopf-1 Inhibition Reactivates Wnt/β-Catenin Signaling in Rhabdomyosarcoma, Induces Myogenic Markers In Vitro and Impairs Tumor Cell Survival In Vivo
Irina Giralt et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
WNT/β-Catenin Pathway in Soft Tissue Sarcomas: New Therapeutic Opportunities?
Esther Martinez-Font et al.
CANCERS (2021)
Non-targeting control for MISSION shRNA library silences SNRPD3 leading to cell death or permanent growth arrest
Maria Czarnek et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
The WNT5A Agonist Foxy5 Reduces the Number of Colonic Cancer Stem Cells in a Xenograft Mouse Model of Human Colonic Cancer
Janina Osman et al.
ANTICANCER RESEARCH (2019)
The Emerging Roles of Cancer Stem Cells and Wnt/Beta-Catenin Signaling in Hepatoblastoma
Nirmala Mavila et al.
CANCERS (2019)
Rhabdomyosarcoma
Stephen X. Skapek et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Up-regulation of Wnt5a inhibits proliferation and migration of hepatocellular carcinoma cells
Tianxiao Wang et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2019)
The Transcriptional Coactivator TAZ Is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis
Michael D. Deel et al.
CLINICAL CANCER RESEARCH (2018)
Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotype
Tobias Sinnberg et al.
MOLECULAR CANCER (2018)
Canonical WNT/beta-Catenin Signaling Plays a Subordinate Role in Rhabdomyosarcomas
Nada Ragab et al.
FRONTIERS IN PEDIATRICS (2018)
LEF1 reduces tumor progression and induces myodifferentiation in a subset of rhabdomyosarcoma
Julia Draeger et al.
ONCOTARGET (2017)
SOST silencing promotes proliferation and invasion and reduces apoptosis of retinoblastoma cells by activating Wnt/β-catenin signaling pathway
T. Wu et al.
GENE THERAPY (2017)
A Novel Notch-YAP Circuit Drives Stemness and Tumorigenesis in Embryonal Rhabdomyosarcoma
Katherine K. Slemmons et al.
MOLECULAR CANCER RESEARCH (2017)
A multi-shRNA vector enhances the silencing efficiency of exogenous and endogenous genes in human cells
Yanjie Weng et al.
ONCOLOGY LETTERS (2017)
Myogenic regulatory transcription factors regulate growth in rhabdomyosarcoma
Ines M. Tenente et al.
ELIFE (2017)
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
Roel Nusse et al.
CELL (2017)
Hedgehog/Patched-associated rhabdomyosarcoma formation from delta1-expressing mesodermal cells
F. Nitzki et al.
ONCOGENE (2016)
Activation of Wnt/β-Catenin in Ewing Sarcoma Cells Antagonizes EWS/ETS Function and Promotes Phenotypic Transition to More Metastatic Cell States
Elisabeth A. Pedersen et al.
CANCER RESEARCH (2016)
WNT5A and Its Receptors in the Bone-Cancer Dialogue
Stefanie Thiele et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
Secreted Frizzled-Related Protein 3 (SFRP3) Is Required for Tumorigenesis of PAX3-FOXO1-Positive Alveolar Rhabdomyosarcoma
Julie J. G. Kephart et al.
CLINICAL CANCER RESEARCH (2015)
WNT5A Has Anti-Prostate Cancer Effects In Vitro and Reduces Tumor Growth in the Skeleton In Vivo
Stefanie Thiele et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
Targeting MYC Translation in Colorectal Cancer
Alina Castell et al.
CANCER DISCOVERY (2015)
WNT5A promotes stemness characteristics in nasopharyngeal carcinoma cells leading to metastasis and tumorigenesis
Li Qin et al.
ONCOTARGET (2015)
Migration and invasion of oral squamous carcinoma cells is promoted by WNT5A, a regulator of cancer progression
Zdenka Prgomet et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2015)
Wnt5a Suppresses Colon Cancer by Inhibiting Cell Proliferation and Epithelial-Mesenchymal Transition
Runfen Cheng et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2014)
Survivin Blockade Sensitizes Rhabdomyosarcoma Cells for Lysis by Fetal Acetylcholine Receptor-Redirected T Cells
Katja Simon-Keller et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Targeting Oxidative Stress in Embryonal Rhabdomyosarcoma
Xiang Chen et al.
CANCER CELL (2013)
PI3K/Akt-dependent phosphorylation of GSK3β and activation of RhoA regulate Wnt5a-induced gastric cancer cell migration
Jiaojing Liu et al.
CELLULAR SIGNALLING (2013)
Characterization of Wnt/β-catenin signaling in rhabdomyosarcoma
Srinivas R. Annavarapu et al.
LABORATORY INVESTIGATION (2013)
Wnt/β-Catenin Signaling and Disease
Hans Clevers et al.
CELL (2012)
A uniform human Wnt expression library reveals a shared secretory pathway and unique signaling activities
Rani Najdi et al.
DIFFERENTIATION (2012)
Wnt signaling in myogenesis
Julia von Maltzahn et al.
TRENDS IN CELL BIOLOGY (2012)
Wnt/Ca2+ signaling pathway: a brief overview
Antara De
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2011)
CD133 Positive Embryonal Rhabdomyosarcoma Stem-Like Cell Population Is Enriched in Rhabdospheres
Dagmar Walter et al.
PLOS ONE (2011)
Impaired Wnt Signaling in Embryonal Rhabdomyosarcoma Cells from p53/c-fos Double Mutant Mice
Shalini Singh et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Wnt5a regulates distinct signalling pathways by binding to Frizzled2
Akira Sato et al.
EMBO JOURNAL (2010)
Fusion Gene-Negative Alveolar Rhabdomyosarcoma Is Clinically and Molecularly Indistinguishable From Embryonal Rhabdomyosarcoma
Daniel Williamson et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Muscling in Uncovering the origins of rhabdomyosarcoma
Simone Hettmer et al.
NATURE MEDICINE (2010)
Heat shock cognate 70 protein secretion as a new growth arrest signal for cancer cells
P. Nirde et al.
ONCOGENE (2010)
Molecular Classification of Rhabdomyosarcoma-Genotypic and Phenotypic Determinants of Diagnosis A Report from the Children's Oncology Group
Elai Davicioni et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Ror2 Receptor Requires Tyrosine Kinase Activity to Mediate Wnt5A Signaling
Amanda Mikels et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Wif-1 is expressed at cartilage-mesenchyme interfaces and impedes Wnt3a-mediated inhibition of chondrogenesis
Cordula Surmann-Schmitt et al.
JOURNAL OF CELL SCIENCE (2009)
Beta-Catenin Mutation Does Not Seem to Have an Effect on the Tumorigenesis of Pediatric Rhabdomyosarcomas
Dorothee Bouron-Dal Soglio et al.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2009)
WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer
Jianming Ying et al.
CLINICAL CANCER RESEARCH (2008)
Wnt5a modulates glycogen synthase kinase 3 to induce phosphorylation of receptor tyrosine kinase Ror2
Hiroyuki Yamamoto et al.
GENES TO CELLS (2007)
Purified Wnt5a protein activates or inhibits β-catenin-TCF signaling depending on receptor context
AJ Mikels et al.
PLOS BIOLOGY (2006)
Wnt-5a has tumor suppressor activity in thyroid carcinoma
N Kremenevskaja et al.
ONCOGENE (2005)
Low expression of Wnt-5a gene is associated with high-risk neuroblastoma
E Blanc et al.
ONCOGENE (2005)
Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent β-catenin degradation
L Topol et al.
JOURNAL OF CELL BIOLOGY (2003)
The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signalling pathway
I Oishi et al.
GENES TO CELLS (2003)
Lentivirus-delivered stable gene silencing by RNAi in primary cells
SA Stewart et al.
RNA (2003)
Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma
AT Weeraratna et al.
CANCER CELL (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Share Paper
